Friedman Brain Institute
The Friedman Brain Institute is an interdisciplinary hub for defining the mechanisms underlying brain and nervous system diseases and for translating those findings into preventative or restorative interventions. The Institute is focused on three major areas of investigation where Mount Sinai can be truly transformative: neural injury and repair, cognition, and neuropsychiatry. The Institute will be judged by its success in advancing brain repair, developing new ways to advance cognition, and improving the treatment of neuropsychiatric disorders.
The Brain Institute's work spans basic molecular and genetic research of nervous system disorders, from animal models to investigations of human populations in the clinic. New knowledge from animal studies will drive clinical investigations, while new insight from clinical studies will help guide more basic exploration into the underlying mechanisms. This broad-based approach incorporates a wide range of state-of-the-art methodologies and coordinates efforts among numerous departments at the Icahn School of Medicine, including neuroscience, neurology, psychiatry, neurosurgery, pharmacology, geriatrics, ophthalmology, and rehabilitative medicine.
Mount Sinai has been recognized as a leader in brain research and treatment for over a century. It has been at the forefront of the rapidly evolving discipline of basic neuroscience, while its longstanding reputation for excellence in clinical neurology, neurosurgery, psychiatry, ophthalmology, and rehabilitative medicine has continued to grow.
Friedman Brain Institute [PDF]